Statins in heart failure: do we need another trial? | Zendy

Amudha Kadirvelu | Zendy; 오세이 | Zendy; Daniel D. Reidpath | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Statins in heart failure: do we need another trial?

Author(s) -

Amudha Kadirvelu,

오세이,

Daniel D. Reidpath

Publication year - 2013

Publication title -

vascular health and risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.892

H-Index - 68

eISSN - 1178-2048

pISSN - 1176-6344

DOI - 10.2147/vhrm.s44499

Subject(s) - medicine , heart failure , observational study , randomized controlled trial , cardiology , statin , clinical trial , intensive care medicine , physical therapy

Statins lower serum cholesterol and are employed for primary and secondary prevention of cardiovascular events. Clinical evidence from observational studies, retrospective data, and post hoc analyses of data from large statin trials in various cardiovascular conditions, as well as small scale randomized trials, suggest survival and other outcome benefits for heart failure. Two recent large randomized controlled trials, however, appear to suggest statins do not have beneficial effects in heart failure. In addition to lowering cholesterol, statins are believed to have many pleotropic effects which could possibly influence the pathophysiology of heart failure. Following the two large trials, evidence from recent studies appears to support the use of statins in heart failure. This review discusses the role of statins in the pathophysiology of heart failure, current evidence for statin use in heart failure, and suggests directions for future research.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research